Pleasant Hill, CA, United States of America

Peichao Lu

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Malden, MA (US) (2011 - 2012)
  • Cambridge, MA (US) (2012)
  • Pleasant Hill, CA (US) (2015 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Peichao Lu: Innovator in Pharmaceutical Compounds

Introduction

Peichao Lu is a prominent inventor based in Pleasant Hill, CA, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable advancements in the treatment of various diseases.

Latest Patents

Among his latest patents, Peichao Lu has developed compounds and compositions for the treatment of cryptosporidiosis. This invention relates to compounds of Formula I, which are designed to combat this parasitic infection. Additionally, he has created antiviral pyridopyrazinedione compounds, which provide compounds of Formula (I) along with pharmaceutically acceptable salts and pharmaceutical compositions. These innovations are particularly aimed at treating viral infections, especially those caused by herpesviruses.

Career Highlights

Peichao Lu is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research and development in the pharmaceutical sector.

Collaborations

Throughout his career, Peichao Lu has collaborated with notable colleagues, including Jiping Fu and Subramanian Karur. These partnerships have contributed to the success of his innovative projects.

Conclusion

Peichao Lu's contributions to pharmaceutical innovations highlight his expertise and dedication to improving healthcare solutions. His work continues to impact the field positively, showcasing the importance of research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…